The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Neutrophil to lymphocyte ratio and cardiovascular diseases: a review
Abstract
The role of inflammatory markers in cardiovascular diseases has been studied extensively and a consistent relationship between various inflammatory markers and cardiovascular diseases has been established in the past. Neutrophil to lymphocyte ratio (NLR) is a new addition to the long list of these inflammatory markers. NLR, which is calculated from complete blood count with differential, is an inexpensive, easy to obtain, widely available marker of inflammation, which can aid in the risk stratification of patients with various cardiovascular diseases in addition to the traditionally used markers. It has been associated with arterial stiffness and high coronary calcium score, which are themselves significant markers of cardiovascular disease. NLR is reported as an independent predictor of outcome in stable coronary artery disease, as well as a predictor of short- and long-term mortality in patients with acute coronary syndromes. It is linked with increased risk of ventricular arrhythmias during percutaneous coronary intervention (PCI) and higher long-term mortality in patients undergoing PCI irrespective of indications of PCI. In patients admitted with advanced heart failure, high NLR was reported with higher inpatient mortality. Recently, NLR has been reported as a prognostic marker for outcome from coronary artery bypass grafting and postcoronary artery bypass grafting atrial fibrillation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Only emphysema and heart failure which are known to be strongly associated with increased neutrophil counts37,38 demonstrated particularly high associations.”
From Longitudinal Analysis of Blood Markers Reveals Progressive Loss of Resilience and Predicts Human Lifespan Limit (2021) · cites this paper as [38]
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Inflammation as a risk factor for atrial fibrillation
Aviles, R. J., Martin, D. O., Apperson-Hansen, C., Houghtaling, P. L., Rautaharju, P., Kronmal, R. A., Tracy, R. P., Van Wagoner, D. R., Psaty, B. M., Lauer, M. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103131.70301.4f · Cited by 1,425
Azab, B., Zaher, M., Weiserbs, K. F., Torbey, E., Lacossiere, K., Gaddam, S., Gobunsuy, R., Jadonath, S., Baldari, D., McCord, D., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.062 · Cited by 524
Flagged first, then by citations
Research works printed but not linked: 39
- Ates, 2011, Cardiol. J., 18, 371, 10.5603/CJ.2011.0045 · DOI
- Buckley, 2009, Ann. Intern. Med., 151, 483, 10.7326/0003-4819-151-7-200910060-00009 · DOI
- Danesh, 1998, JAMA, 279, 1477, 10.1001/jama.279.18.1477 · DOI
- Ensrud, 1992, Am. Heart J., 124, 207, 10.1016/0002-8703(92)90942-O · DOI
- Lee, 2001, Am. J. Epidemiol., 154, 758, 10.1093/aje/154.8.758 · DOI
- Guasti, 2011, Thromb. Haemost., 106, 591, 10.1160/TH11-02-0096 · DOI
- Pearson, 2003, Circulation, 107, 499, 10.1161/01.CIR.0000052939.59093.45 · DOI · Paper page
- Olivares, 1993, Am. J. Epidemiol., 137, 49, 10.1093/oxfordjournals.aje.a116601 · DOI
- Horne, 2005, J. Am. Coll. Cardiol., 45, 1638, 10.1016/j.jacc.2005.02.054 · DOI
- Papa, 2008, Clin. Chim. Acta, 395, 27, 10.1016/j.cca.2008.04.019 · DOI
- Kalay, 2012, Angiology, 63, 213, 10.1177/0003319711412763 · DOI
- Park, 2011, Clin. Chim. Acta, 412, 925, 10.1016/j.cca.2011.01.021 · DOI
- Tsai, 2007, Diabetes Metab. Res. Rev., 23, 111, 10.1002/dmrr.647 · DOI
- McCaig, 2001, Adv. Data, 320, 1
- Takakuwa, 2008, Radiology, 248, 438, 10.1148/radiol.2482072169 · DOI
- Romagnoli, 2010, Radiol. Med., 115, 341, 10.1007/s11547-009-0482-7 · DOI
- Mingels, 2012, PLoS ONE, 7, e35059, 10.1371/journal.pone.0035059 · DOI
- Zazula, 2008, Arq. Bras. Cardiol., 90, 31, 10.1590/S0066-782X2008000100006 · DOI
- Li, 2009, Chin. Med. J., 122, 1738
- Muhmmed Suliman, 2010, Arch. Med. Res., 41, 618, 10.1016/j.arcmed.2010.11.006 · DOI
- Tamhane, 2008, Am. J. Cardiol., 102, 653, 10.1016/j.amjcard.2008.05.006 · DOI
- Duffy, 2006, Am. J. Cardiol., 97, 993, 10.1016/j.amjcard.2005.10.034 · DOI
- Poludasu, 2009, Clin. Cardiol., 32, E6, 10.1002/clc.20503 · DOI
- Núñez, 2008, Am. J. Cardiol., 101, 747, 10.1016/j.amjcard.2007.11.004 · DOI
- Cho, 2011, Am. J. Cardiol., 107, 849, 10.1016/j.amjcard.2010.10.067 · DOI
- Kruk, 2008, Circ. J., 72, 205, 10.1253/circj.72.205 · DOI
- Blangy, 2007, Europace, 9, 724, 10.1093/europace/eum102 · DOI
- Konstantino, 2007, Clin. Cardiol., 30, 408, 10.1002/clc.20110 · DOI
- 10.1034/j.1399-6576.2003.00145.x · DOI
- Wu, 2012, Circ. Cardiovasc. Imaging, 5, 178, 10.1161/CIRCIMAGING.111.968024 · DOI
- Chatterjee, 2011, Cardiovasc. Hematol. Disord. Drug Targets, 11, 58, 10.2174/187152911798346981 · DOI
- Cooper, 1999, Am. J. Cardiol., 84, 252, 10.1016/S0002-9149(99)00272-6 · DOI
- Engström, 2009, Circ. Heart Fail., 2, 217, 10.1161/CIRCHEARTFAILURE.108.827071 · DOI
- Arruda-Olson, 2009, Circ. Cardiovasc. Qual. Outcomes, 2, 656, 10.1161/CIRCOUTCOMES.108.831024 · DOI
- Kyne, 2000, Am. Heart J., 139, 94, 10.1016/S0002-8703(00)90314-4 · DOI
- Rudiger, 2006, Am. J. Emerg. Med., 24, 451, 10.1016/j.ajem.2005.10.010 · DOI
- Uthamalingam, 2011, Am. J. Cardiol., 107, 433, 10.1016/j.amjcard.2010.09.039 · DOI
- Gibson, 2007, Am. Heart J., 154, 995, 10.1016/j.ahj.2007.06.043 · DOI · Paper page
- Gibson, 2010, Am. J. Cardiol., 105, 186, 10.1016/j.amjcard.2009.09.007 · DOI
Cited by
Sorted by citations
Neutrophil-to-lymphocyte ratio and mortality in the United States general population
Song, M., Graubard, B. I., Rabkin, C. S., & Engels, E. A. (2021) · Scientific Reports · doi:10.1038/s41598-020-79431-7 · Cited by 434
Jin, Z., Wu, Q., Chen, S., Gao, J., Li, X., Zhang, X., Zhou, Y., He, D., Cheng, Z., Zhu, Y., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s283835 · Cited by 312
Pyrkov, T. V., Avchaciov, K., Tarkhov, A. E., Menshikov, L. I., Gudkov, A. V., & Fedichev, P. O. (2021) · Nature Communications · doi:10.1038/s41467-021-23014-1 · Cited by 139
Demircan, F., Gözel, N., Kılınç, F., Ulu, R., & Atmaca, M. (2016) · Neurology and Therapy · doi:10.1007/s40120-015-0039-8 · Cited by 128
Cosentino, M., Marino, F., & Maestroni, G. J. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00302 · Cited by 63
Bulut, N. S., Yorguner, N., & Çarkaxhiu Bulut, G. (2021) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2021.1919201 · Cited by 63
Ye, Z., Ai, X., Liao, Z., You, C., & Cheng, Y. (2019) · Medicine · doi:10.1097/md.0000000000016371 · Cited by 57
Ramos-Cejudo, J., Johnson, A. D., Beiser, A., Seshadri, S., Salinas, J., Berger, J. S., Fillmore, N. R., Do, N., Zheng, C., Kovbasyuk, Z., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.773984 · Cited by 49
Zhao, L., Dai, Q., Chen, X., Li, S., Shi, R., Yu, S., Yang, F., Xiong, Y., & Zhang, R. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.11.012 · Cited by 46
Insight into the Evolving Role of PCSK9
Maligłówka, M., Kosowski, M., Hachuła, M., Cyrnek, M., Bułdak, Ł., Basiak, M., Bołdys, A., Machnik, G., Bułdak, R. J., & Okopień, B. (2022) · Metabolites · doi:10.3390/metabo12030256 · Cited by 41
Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID‐19
Pillat, M. M., Krüger, A., Guimarães, L. M. F., Lameu, C., de Souza, E. E., Wrenger, C., & Ulrich, H. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24190 · Cited by 17
Metadata
- Authors
- Bhat, T., Teli, S., Rijal, J., Bhat, H., Raza, M., Khoueiry, G., Meghani, M., Akhtar, M., & Costantino, T.
- Venue
- Expert Review of Cardiovascular Therapy
- Publisher
- Informa UK Limited
- Published
- 2013-01
- Volume
- 11
- Issue
- 1
- Pages
- 55-59
- ISSN
- 1477-9072
- 1744-8344
- Cited by
- 600
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review